Method for industrially producing cyclic-structure-containing branched glucan
    2.
    发明授权
    Method for industrially producing cyclic-structure-containing branched glucan 有权
    工业生产含环状结构的支链葡聚糖的方法

    公开(公告)号:US09562247B2

    公开(公告)日:2017-02-07

    申请号:US13992205

    申请日:2011-12-02

    摘要: An object of the present invention is to provide a method for industrially producing a branched glucan having a cyclic structure. The method for producing a branched glucan having a cyclic structure comprises the steps of: (1) preparing a mixed liquid which contains a branching enzyme in which starch granules are suspended at a concentration of 5% by weight or more and 50% by weight or less, and allowing the branching enzyme to act on starch in the starch granules, wherein a temperature of the mixed liquid at the time of preparation is 0° C. or higher and not higher than the gelatinization starting temperature of the starch granule; and (2) elevating the temperature of the mixed liquid to 85° C. or higher and 129° C. or lower, wherein in the method, none of α-amylase, β-amylase, amyloglucosidase and αtransglucosidase is added to the mixed liquid.

    摘要翻译: 本发明的目的是提供一种工业生产具有环状结构的支链葡聚糖的方法。 制备具有环状结构的支链葡聚糖的方法包括以下步骤:(1)制备含有淀粉颗粒以5重量%以上至50重量%的浓度悬浮的分支酶的混合液,或 较少,并且使分支酶对淀粉颗粒中的淀粉起作用,其中制备时的混合液的温度为0℃以上且不高于淀粉颗粒的糊化开始温度; 和(2)将混合液体的温度升高至85℃以上且129℃以下,在该方法中,在混合液中不添加α-淀粉酶,β-淀粉酶,淀粉葡糖苷酶和α转葡糖苷酶 。

    Method of using isomaltulose to suppress blood glucose level increase
    6.
    发明授权
    Method of using isomaltulose to suppress blood glucose level increase 有权
    使用异麦芽酮糖抑制血糖水平升高的方法

    公开(公告)号:US09017744B2

    公开(公告)日:2015-04-28

    申请号:US12832933

    申请日:2010-07-08

    摘要: A method for reducing blood glucose level increase is provided that includes: providing a reducer of blood glucose level increase, wherein the reducer comprises isomaltulose; having an individual ingest the reducer; and having the individual consume a carbohydrate having an α-1,6-glucosyl bond ratio of from 0% to less than 50% relative to the total bonds among constituent saccharides, wherein the reducer is ingested before or after or simultaneously with consuming the carbohydrate, and wherein the reducer reduces an increase in the individual's blood glucose level caused by consuming the carbohydrate. The reducer of blood glucose level increase includes isomaltulose (PALATINOSE™) as an active ingredient so that when the reducer is ingested and a carbohydrate having an α-1,6-glucosyl bond ratio of from 0% to less than 50% relative to the total bonds among constituent saccharides is consumed, an increase in blood glucose level caused by ingesting the carbohydrate is reduced.

    摘要翻译: 提供了降低血糖水平升高的方法,其包括:提供血糖水平升高的还原剂,其中所述还原剂包含异麦芽酮糖; 有个人摄入减速机; 并且使所述个体相对于构成糖中的总键消耗具有0%至小于50%的α-1,6-葡糖基键比例的碳水化合物,其中所述还原剂在消耗碳水化合物之前或之后或同时摄取 ,并且其中所述还原剂减少由消耗碳水化合物引起的个体血糖水平的增加。 血浆葡萄糖水平升高的还原剂包括异麦芽酮糖(PALATINOSE TM)作为活性成分,使得当所述还原剂摄取时,具有0至小于50%的α-1,6-葡糖基键比例的碳水化合物相对于 消耗组成糖中的总键,减少摄取碳水化合物引起的血糖水平升高。

    HYPOGLYCEMIC HYPER-BRANCHED MALTODEXTRINS
    7.
    发明申请
    HYPOGLYCEMIC HYPER-BRANCHED MALTODEXTRINS 有权
    超高分子超分子金属蛋白酶

    公开(公告)号:US20150025037A1

    公开(公告)日:2015-01-22

    申请号:US14379362

    申请日:2013-02-27

    申请人: ROQUETTE FRERES

    摘要: Hyper-branched maltodextrins having a dextrose equivalent (DE) between at least 8 and at most 15 and a molecular weight or Mw between at least 1,700 and at most 3,000 daltons, characterized in that same have: a 1,6 glucoside bond content between at least 30 and at most 45%; a soluble indigestible fiber content, which is determined according to the AOAC No. 2001-03 method, between at least 75 and at most 100%; and a hypoglycemic capacity expressed according to a test A, which:—in vitro, results in an 80 to 90% reduction of the α-amylase hydrolysis of standard maltodextrins, and—in situ, by a 30 to 45% reduction in the intestinal digestive activity of standard maltodextrins.

    摘要翻译: 具有至少8和至多15之间的葡萄糖当量(DE)和分子量或至少1,700至至多3,000道尔顿之间的Mw的超支化麦芽糖糊精,其特征在于,其具有:在 至少30和最多45%; 根据AOAC No.2001-03方法测定的至少75至最多100%的可溶消化纤维含量; 和根据试验A表达的降血糖能力,其中: - 体外,导致标准麦芽糖糊精的α-淀粉酶水解降低80-90%,并且原位降低肠中30〜45% 标准麦芽糖糊精的消化活性。